Smits J F, van Essen H, Struyker-Boudier H A, Lappe R W
Life Sci. 1986 Jan 6;38(1):81-7. doi: 10.1016/0024-3205(86)90278-x.
Synthetic atriopeptin II (APII) was infused directly into the right renal artery of intact conscious SHR at rates of 0.25-1 microgram/kg/min, while simultaneously measuring blood pressure (MAP) and selected regional blood flows. The latter were measured using chronically implanted miniaturized Doppler flowprobes that were placed on the right and left renal artery, superior mesenteric artery and abdominal aorta. The effects of intrarenally (i.r.) infused APII on these vascular beds were compared to the effects of the same amounts of APII given intravenously (i.v.) in the same SHR. I.r. and i.v. infusions caused similar reductions of MAP and all four blood flows. Also effects on calculated resistances were comparable, implying that resistance increased most in the mesentery and least in the two kidneys. The increase in right renal resistance during i.v. infusions of APII was not different from the effect during i.r. infusions. Also, during i.r. infusions into the right kidney, effects on the left and right kidney were not different. Our observations suggest that synthetic APII has no direct effects on the renal vasculature of intact conscious SHR.
将合成的心房肽II(APII)以0.25 - 1微克/千克/分钟的速率直接注入清醒的完整自发性高血压大鼠(SHR)的右肾动脉,同时测量血压(平均动脉压,MAP)和选定区域的血流。后者通过长期植入的小型多普勒血流探头进行测量,这些探头分别置于左右肾动脉、肠系膜上动脉和腹主动脉上。将肾内(i.r.)注入APII对这些血管床的影响与相同剂量的APII静脉内(i.v.)注入同一SHR的效果进行比较。肾内和静脉内注入导致MAP和所有四种血流出现类似程度的降低。对计算出的阻力的影响也具有可比性,这意味着肠系膜中的阻力增加最多,而两个肾脏中的阻力增加最少。静脉内注入APII期间右肾阻力的增加与肾内注入期间的效果无差异。此外,在向右侧肾脏进行肾内注入时,对左肾和右肾的影响无差异。我们的观察结果表明,合成的APII对清醒的完整SHR的肾血管系统没有直接影响。